Uses of Genotyping.

Slides:



Advertisements
Similar presentations
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
Advertisements

TB in Tennessee The Good, the Bad, and the Ugly Jason Cummins, MPH April 30, 2014.
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
TB Contact Investigation
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
World Health Organization TB Case Definitions
Nucleic Acid Amplification Test for Tuberculosis
B WAIVERS: A YEAR IN REVIEW MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER,
Case discussion Michael Gardam University Health Network.
Tuberculosis Cluster Investigations Using Genotyping Data Frank Romano, MPH CDC Public Health Advisor.
Principles of Outbreak Management
TB Outbreak in Grand Forks
Andrew Waters Regional Epidemiologist Bluegrass Region 2 Hepatitis A Outbreak 2007 ERRT Conference October 2nd, 2007.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Epidemiology Tools and Methods Session 2, Part 1.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
LESSON 9.5: TYPES OF STUDIES Module 9: Epidemiology Obj. 9.5: Compare & contrast different types of epidemiological studies.
Introduction to Tuberculosis Genotyping National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination.
State and Local STD Prevention Programs Prepared by Jim Lee, Senior Public Health Advisor, Texas Department of State Health Services and Melinda Salmon,
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Preparing for Cohort Review & Standard Forms for Cohort Presentation June 16, 2010 Kieran Hartsough.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
INVESTIGATION of EPIDEMIC. LEARNING OBJECTIVES  Recognize trends of disease occurrence.  Recognize trends of disease occurrence.  Define epidemic and.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Introduction to Contact Investigation Process Amy Schmitt, BSN, RN Public Health Grand Rounds Tuberculosis November 19, 2015.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 10 Field Epidemiology.
Mumps Outbreaks Associated with Correctional Facilities Texas
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Outbreak Investigation
Understanding Epidemiology
National Tuberculosis Genotyping Service
Tuberculosis in children
TB Genotyping and Whole Genome Sequencing in California
Los Angeles County TBCP
HEALTH PROMOTION.
Whole-Genome Sequencing; It’s Not Just For Epis
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
TB- HIV Collaborative activities in Romania- may 2006 status
Outbreak Investigations
This is an archived document.
Utah Zika investigation, July 2016
Treatment of Latent TB Infection (LTBI)
EPIDEMIC INVESTIGATION
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Presentation 10 Analysing results and defining cases
Disease Detective Team!
بسم الله الرحمن الرحيم.
NJMS Global TB Institute
Mark Lobato, MD Division of TB Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Use Case Scenarios Leveraging Public Health’s Experience with Information Standards and Health Improvement.
Module 9 Recording and reporting culture results
Public Health Surveillance
Using Whole Genome Sequencing Analysis in California
Division of Tuberculosis Elimination
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Perspectives from Los Angeles County Tuberculosis Control Program
Laura Lane, Epidemiologist
Illustrative Cluster Detection and Response Strategy
Lab Results + RVCT Notification=
Surveillance: From Patient to CDC
Presentation transcript:

Uses of Genotyping

Objectives Identify uses for genotyping in TB control efforts Explore false-positive situations Distinguish between contact investigations and cluster investigations Define how genotyping can support identification of new vs old infection

Genotyping is used to.. Detect false-positive culture results Enhance investigations Confirm/refute links Identify unknown contacts Distinguish relapse from new infection Monitor trends and evaluate TB control program Differentiate M. bovis and M. bovis BCG

False-Positive (FP)

False-Positive Possible causes Consequences Clerical errors: mislabeled specimens Laboratory cross- contamination Clinical device contamination: bronchoscope Consequences Incorrect TB diagnosis Unnecessary use of resources Delay in correct diagnosis or treatment Overestimation of the TB case rate - Note these are commonly called lab contaminations but these can be caused by other sources.

False-Positive: Scenario Case: 52 year-old male Sputum specimen (one collected) M. tb culture- positive AFB smear negative Chest radiograph- normal Asymptomatic and no risk factors (i.e. HIV, drug use, incarceration, homeless shelter) Began isoniazid, rifampin, ethambutol regimen Developed hepatitis-medications discontinued Condition did not worsen Hospitalized with laryngeal cancer Positive culture is enough to make an individual a confirmed TB case. Treating physician did not believe he was a TB case; wanted to rule out laryngeal TB

False-Positive: Scenario Hint #1: Two TB suspects admitted at the same time Two identical genotypes from same hospital lab within two sequential days Of 12,000 genotypes run in Texas in 10 years, only 6 resulted in same genotype Hint #2: Contact investigation did not reveal any suspect cases from FP case Clearly lab contamination… Right?

False-Positive (FP): Scenario Other clues: Only 1 specimen collected for FP patient and two specimens for the other– this was a burning question! GENType– very rare strain Suspected FP had no other clinical sx’s No Epi-links between the two hospitalized individuals

False-Positive: Scenario Summary of findings In total, three specimens under review, all collected on successive days All specimens collected at one hospital, but processed at another, all on successive days Two genotyped specimens matched Both individuals were in hospital on same day No epidemiological links between the individuals Conclusion: Second specimen was that of the “true” TB case but was mislabeled with the wrong name.

False-Positive: Scenario Process for Investigation Created a working group involving Central Office: nurses, epidemiologists, TB Program Manager, surveillance, laboratory Regional Office: TB Program Manager, nurses, case manager Heartland Held regular conference calls to discuss Updates on case progress Evolving questions Discussions with local hospital staff to understand process of patient care and laboratory procedures Moving forward Team regularly reviews suspected false-positive cases Working to create policies to share with regional and local programs - If a case is reported and then reversed ALL of those cases will be reviewed

Enhance Investigations

Quick Epidemiology Overview Along with the genotype data, we need to see if the cases are epidemiologically linked as well to determine recent transmission. Definition of Epidemiologic link (Epi-link) A characteristic two TB patients share that explains where and when TB could have been transmitted Location where the two persons spent time together (6 or more hours per week) Relationship that brought them together

What is an Epi-Link? Epidemiologic links are essential to determine on-going transmission: Person – demographic information Place – bars, jail, homeless shelter, geographic location Time – infectious period of index Hours of exposure Relates to infectious period Elaborate on infectious period Place can also be determined by what types of activities the individual is involved in (church choir, drinking, hobbies such as playing pool, card games)

Types of Epi-Links Definite Probable Possible No Epi-links TB Case named the other OR TB case in the same place at the same time during infectious period TB cases in same area and shared social or behavioral traits TB cases live in same neighborhood around the same time TB case in the same place, but timing is off No links identified

Enhance investigations Two Types of Investigations: Contact Investigations Cluster Investigations

Contact Investigations An investigation of persons who have shared space/time with a patient having infectious TB. Goal: Identify additional persons with active TB Determine if transmission occurred between the TB patient and their contacts, and To identify persons with latent TB infection who are candidates for treatment Involves interviewing TB cases and suspects

Contact Investigations Genotyping can help: Identify persons involved in same chain of transmission Confirm links Refute Links Identify unknown contacts

Challenges Missing information on TB-340’s Date of broken contact Names of bars, restaurants, shelters, or other places of social activities Diagnosis dates, dates of symptom onset, or other relevant dates Unidentified contacts Case is unwilling to reveal the name of contact Case did not know the name of contact Case unable to provide information (i.e. dead, dementia) - Genotyping can assist with unidentified contacts

Designation of Clusters More than one isolate has the same GENType Unique No matched GENType indicates it is a unique strain (i.e. not clustered)

Cluster Investigation An investigation of TB patients who share epidemiologic links after genotyping results are known Goal: To identify epidemiologic links among TB patients whose isolates have matching GENTypes to see if any contacts were missed. Genotyping is critical to initiate cluster investigations and follows contact investigations if there is suspicion of an outbreak. May consist of reviewing medical info or re-interviewing patient.

Launching a cluster investigation Movement from PCRType to GENType, i.e. G16274 Cluster alerts from TBGIMS Log Likelihood Ratio Cluster investigations are not always warranted We are here to help guide you and assist you when deciding on whether or not to launch a full investigation. Genotyping coordinator monitors cluster alerts Creating a workgroup to assess and determine need for further investigation Discuss LLR Alert levels in TB GIMS are based on geospatial concentration Statistic: Log Likelihood Ratio (LLR) On the county level High (3-year LLR≥10) Medium (3-year LLR = 5.0 to 9.99) None (3-year LLR ≤ 4.99)

Possible Indicators for Ongoing Transmission/ Outbreak Homeless clusters Pediatric cases, drug resistant cases, other risk factors High geographic concentration Increasing numbers over time (Epi curve)

Contact Cluster Who? Contacts Cases What? New cases/suspects Linked cases (Genotyping/Epi-links) When? Upon identification of case/suspect After contact investigation and genotyping Where? Home/work place visit Re-evaluation of home/work How? Interviewing Record interview Social network analysis Re-interview cases Record re-review Review genotype data Additional social network analyses Why? Genotyping may assist in finding missed contacts/expand contact investigations. It can confirm Epi-links. Identify unsuspected transmission.

Distinguish relapse from new infection

New vs Old Infection Reactivation: when TB patient is treated & cured, but has a subsequent episode of TB disease caused by same strain of M. tuberculosis as previous episode Reinfection: caused by 2nd infection with different strain from initial strain Genotyping 1st & 2nd isolates from same patient: can demonstrate reactivation vs reinfection - Reinfection: usually, though it is possible to be reinfected with the same strain if the person continues to be exposed after cure.

Monitor trends and evaluate TB control program

Monitor trends and evaluate TB control program Monitor ongoing transmission Identify trends- characteristics of cluster Known high risk populations Newly identified high risk populations Settings Prioritize prevention and control efforts Monitor progress toward TB elimination goals Quarterly Cohort Reviews Treatment completion Number of contacts

Differentiate M. bovis and M. bovis BCG

M. bovis and M. bovis BCG These cases can be identified via genotyping results M. bovis-warrants further investigation unpasteurized dairy contact with livestock M. bovis BCG- no further investigation required Verify these cases are not reported

Quiz Time! TRUE OR FALSE Genotyping is a good substitute for contact investigations. Answer= False. Genotyping complements contact investigations but does not replace the need for good CI work!

Quiz Time! Genotyping may be especially helpful in identifying places that were: Obvious during the initial contact investigation. Already tested during the initial contact investigation. Overlooked (unusual settings) during the initial contact investigation. Correct answer: C Unusual and overlooked settings can become more clear once genotyping results have been determined.

Reminder Our team is here to help you: Genotype Coordinator: TBGIMS, interpreting results Support for cluster investigation Guide false-positive investigations Assist with questions for contact investigations/guidance

Objectives Identify uses for genotyping in TB control efforts Explore false-positive situations Distinguish between contact investigations and cluster investigations Define how genotyping can support identification of new vs old infection